These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32457420)

  • 21. Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali.
    Safronetz D; Sogoba N; Lopez JE; Maiga O; Dahlstrom E; Zivcec M; Feldmann F; Haddock E; Fischer RJ; Anderson JM; Munster VJ; Branco L; Garry R; Porcella SF; Schwan TG; Feldmann H
    PLoS Negl Trop Dis; 2013; 7(12):e2582. PubMed ID: 24340119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lassa fever diagnostics: past, present, and future.
    Happi AN; Happi CT; Schoepp RJ
    Curr Opin Virol; 2019 Aug; 37():132-138. PubMed ID: 31518896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
    Safronetz D; Mire C; Rosenke K; Feldmann F; Haddock E; Geisbert T; Feldmann H
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003736. PubMed ID: 25884628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.
    Branco LM; Grove JN; Geske FJ; Boisen ML; Muncy IJ; Magliato SA; Henderson LA; Schoepp RJ; Cashman KA; Hensley LE; Garry RF
    Virol J; 2010 Oct; 7():279. PubMed ID: 20961433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challenges.
    Shaffer JG; Schieffelin JS; Gbakie M; Alhasan F; Roberts NB; Goba A; Randazzo J; Momoh M; Moon TD; Kanneh L; Levy DC; Podgorski RM; Hartnett JN; Boisen ML; Branco LM; Samuels R; Grant DS; Garry RF;
    PLoS One; 2019; 14(3):e0214284. PubMed ID: 30921383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report.
    Grove JN; Branco LM; Boisen ML; Muncy IJ; Henderson LA; Schieffellin JS; Robinson JE; Bangura JJ; Fonnie M; Schoepp RJ; Hensley LE; Seisay A; Fair JN; Garry RF
    Virol J; 2011 Jun; 8():314. PubMed ID: 21689444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current research for a vaccine against Lassa hemorrhagic fever virus.
    Warner BM; Safronetz D; Stein DR
    Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic characterization of Lassa virus strains isolated from 2012 to 2016 in southeastern Nigeria.
    Oloniniyi OK; Unigwe US; Okada S; Kimura M; Koyano S; Miyazaki Y; Iroezindu MO; Ajayi NA; Chukwubike CM; Chika-Igwenyi NM; Ndu AC; Nwidi DU; Abe H; Urata S; Kurosaki Y; Yasuda J
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006971. PubMed ID: 30500827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use.
    Ter Meulen J; Koulemou K; Wittekindt T; Windisch K; Strigl S; Conde S; Schmitz H
    J Clin Microbiol; 1998 Nov; 36(11):3143-8. PubMed ID: 9774554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Field evaluation of validity and feasibility of Pan-Lassa rapid diagnostic test for Lassa fever in Abakaliki, Nigeria: a prospective diagnostic accuracy study.
    Elsinga J; Sunyoto T; di Stefano L; Giorgetti PF; Kyi HA; Burzio C; Campos Moreno X; Ojide CK; Ajayi N; Ewah R; Ogah EO; Dan-Nwafor C; Ahumibe A; Ochu CL; Olayinka A; Jonckheere S; Chaillet P; van Herp M
    Lancet Infect Dis; 2024 May; ():. PubMed ID: 38734012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and Evaluation of a One-Step Quantitative RT-PCR Assay for Detection of Lassa Virus.
    Dedkov VG; Magassouba N'; Safonova MV; Naydenova EV; Ayginin AA; Soropogui B; Kourouma F; Camara AB; Camara J; Kritzkiy AA; Tuchkov IV; Shchelkanov MY; Maleev VV
    J Virol Methods; 2019 Sep; 271():113674. PubMed ID: 31170468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation.
    Bausch DG; Rollin PE; Demby AH; Coulibaly M; Kanu J; Conteh AS; Wagoner KD; McMullan LK; Bowen MD; Peters CJ; Ksiazek TG
    J Clin Microbiol; 2000 Jul; 38(7):2670-7. PubMed ID: 10878062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic diversity among Lassa virus strains.
    Bowen MD; Rollin PE; Ksiazek TG; Hustad HL; Bausch DG; Demby AH; Bajani MD; Peters CJ; Nichol ST
    J Virol; 2000 Aug; 74(15):6992-7004. PubMed ID: 10888638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA.
    Olschläger S; Lelke M; Emmerich P; Panning M; Drosten C; Hass M; Asogun D; Ehichioya D; Omilabu S; Günther S
    J Clin Microbiol; 2010 Jun; 48(6):2009-13. PubMed ID: 20351210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Undiagnosed acute viral febrile illnesses, Sierra Leone.
    Schoepp RJ; Rossi CA; Khan SH; Goba A; Fair JN
    Emerg Infect Dis; 2014 Jul; 20(7):1176-82. PubMed ID: 24959946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection.
    Trappier SG; Conaty AL; Farrar BB; Auperin DD; McCormick JB; Fisher-Hoch SP
    Am J Trop Med Hyg; 1993 Aug; 49(2):214-21. PubMed ID: 8357084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.
    Safronetz D; Rosenke K; Westover JB; Martellaro C; Okumura A; Furuta Y; Geisbert J; Saturday G; Komeno T; Geisbert TW; Feldmann H; Gowen BB
    Sci Rep; 2015 Oct; 5():14775. PubMed ID: 26456301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers.
    Gale TV; Horton TM; Grant DS; Garry RF
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005943. PubMed ID: 28922385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lassa fever, Nigeria, 2003 and 2004.
    Omilabu SA; Badaru SO; Okokhere P; Asogun D; Drosten C; Emmerich P; Becker-Ziaja B; Schmitz H; Günther S
    Emerg Infect Dis; 2005 Oct; 11(10):1642-4. PubMed ID: 16355508
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunological screening of Lassa Virus among Health workers and Contacts of patients of Lassa fever in Ondo State.
    Shaibu JO; Salu OB; Amoo OS; Idigbe I; Musa AZ; Ezechi OC; Abejegah C; Ayodeji O; Salako BL; Omilabu SA; Audu RA
    Immunobiology; 2021 May; 226(3):152076. PubMed ID: 33689957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.